| http://www.w3.org/ns/prov#value | - Preferred is a combination (preferably synergistic and/or causing regression up to and including complete cure) of a) at least one oligonucleotide derivative (ODN) targeted to nucleic acids encoding human PKC, especially PKC-??, the oligonucleotide derivative preferably being one that corresponds to an oligonucleotide derivative as published in PCT application WO 93/19203 or WO 95/02069, especiall
|
